EAMA Sarcopenia in Acute Care Patients in 9+European Countries

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

366 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-03-06

Study Completion Date

2023-04-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This collaborative study in 9 geriatrics units across Europe aims to apply emerging research to clinical practice, following the "Action-Research Philosophy" (11). The overall goal is to improve care in patients with - and help prevent - sarcopenia. Understanding the frequency of and risk factors for developing sarcopenia in an acute hospital setting, may help shed light on potential interventions and thus inform the development of future therapeutic strategies. It involves crucial implications for research, clinical practice, and policy towards optimal aging.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Food Intake of Hospitalized Elderly and Its Influence on Muscular and Clinical Outcomes

NCT06940284

Atrophy, Muscular Undernutrition

RECRUITING

Improvement of Sarcopenia in Patients Following Two Different Diets

NCT03405727

Sarcopenia

WITHDRAWN NA

Exercise and Nutrition Interventions in Age-related Sarcopenia

NCT02912130

Sarcopenia Muscular Atrophy

COMPLETED NA

Sarcopenia in Patients With Heart Failure

NCT06634316

Sarcopenia

ACTIVE_NOT_RECRUITING NA

The Nutritionist's Educational Intervention on the Protein Intake in Hospitalized Elderly People

NCT05502445

Old Age; Cachexia Dietary Habits Sarcopenia +2 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: Sarcopenia is a nutrition-related disease leading to physical impairment and adverse clinical outcomes. Data regarding its characteristics in hospitalized patients are limited.

Aim: This study will assess in older patients admitted to acute medical wards, the prevalence, incidence, and risk factors for development of sarcopenia, or alteration in its severity, and evaluate associated clinical adverse outcomes.

Methods: This collaboratively-designed, longitudinal prospective observational study will be carried out in patients aged \>70 admitted to acute geriatric units in 9 European centers. The new sarcopenia diagnostic criteria of the European Working Group on Sarcopenia 2 (EWGSOP2) will be tested at admission and discharge, using isometric handgrip dynamometry, gait speed, and, pragmatically, calf circumference. There will be 3- and 12-month telephone follow-up (including the SARC-F questionnaire).

Discussion: Our study will be the first collaboration to assess the prevalence and incidence of sarcopenia (EWGSOP2) and its risk factors in hospitalized patients across Europe.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia Malnutrition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observational study, no interventions expected

No interventions are planned

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged \>70 admitted to acute hospital medical units

Exclusion Criteria

* Length of hospital stay anticipated to be \<24 hours
* Hip/lower limb fractures
* Major amputations of the lower leg
* Terminally ill patients admitted for palliative care

Minimum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No